当前位置: 首页 > 期刊 > 《中国医药科学》 > 2014年第10期
编号:13128431
阿仑膦酸钠联合辛伐他汀对骨质疏松骨折的影响(3)
http://www.100md.com 2014年5月15日 薛江义等
第1页

    参见附件。

     [8] Martin T,Gooi JH,Sims NA.Molecular mechanisms in coupling of bone formation to resorption [J].Crit Rev Eukaryot Gene Expr,2009,19: 73-88.

    [9] Rozental TD,Vazquez MA,Chacko AT,et al.Comparison of radiographic fracture healing in the distal radius for Patients on and off bisphosphonate therapy[J].J Hand Surg Am,2009,34:595-602.

    [10] Matos MA,Tannuri U,Guarniero R.The effect of zoledronate during bone healing[J].J Orthopaed Traumatol,2010,11:7-12.

    [11] Amanat N,Mcdonald M,Godfrey C,et al.Optimal timing of bolus intravenous zoledronic acid in a rat fracture model[J].J Bone Miner Res,2007,22:867-876.

    [12] Li YF,Zhou CC,Li J,et al.The effects of combined human parathyroid hormone(1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats[J/OL].OsteoporosInt,2011[2011-12-30].

    [13] Bollerslev,JWikon SC,Dick M,et al.LRP5 gene polymorphisms predict bone masss arld irlcident factures in elderly australian wowen[J].Bone,2005,36(4):599-606.

    [14] Tannigo,Takaoka,Tabatay.Sustained release of water-insolublesim vastatin from biodegradable hydrogel augments bone regenerationJ].J Controlled Release,2010,143(2):201-206.

    (收稿日期:2014-03-25)

您现在查看是摘要介绍页,详见PDF附件